Summit Therapeutics Inc (SMMT)
19.00
+0.58
(+3.15%)
USD |
NASDAQ |
Nov 22, 16:00
19.02
+0.02
(+0.11%)
After-Hours: 20:00
Summit Therapeutics Shareholders Equity (Quarterly): 437.92M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 437.92M |
June 30, 2024 | 195.08M |
March 31, 2024 | 44.21M |
December 31, 2023 | 77.69M |
September 30, 2023 | 99.38M |
June 30, 2023 | 119.60M |
March 31, 2023 | 133.48M |
December 31, 2022 | 126.65M |
September 30, 2022 | 133.25M |
June 30, 2022 | 51.32M |
March 31, 2022 | 64.41M |
December 31, 2021 | 83.28M |
September 30, 2021 | 102.30M |
June 30, 2021 | 119.43M |
March 31, 2021 | 64.40M |
December 31, 2020 | 79.45M |
September 30, 2020 | 36.86M |
March 31, 2020 | 67.46M |
October 31, 2019 | 34.65M |
July 31, 2019 | 40.99M |
April 30, 2019 | 49.97M |
January 31, 2019 | 55.79M |
October 31, 2018 | 35.62M |
July 31, 2018 | 43.41M |
April 30, 2018 | 7.950M |
Date | Value |
---|---|
January 31, 2018 | -4.462M |
October 31, 2017 | 21.28M |
July 31, 2017 | 4.600M |
April 30, 2017 | -10.32M |
January 31, 2017 | -4.366M |
October 31, 2016 | 1.330M |
July 31, 2016 | 13.97M |
April 30, 2016 | 23.86M |
January 31, 2016 | 22.90M |
October 31, 2015 | 39.98M |
July 31, 2015 | 47.14M |
April 30, 2015 | 52.25M |
January 31, 2015 | 19.53M |
October 31, 2014 | 28.25M |
July 31, 2014 | 33.82M |
January 31, 2014 | 7.855M |
July 31, 2013 | 8.005M |
January 31, 2013 | 4.503M |
July 31, 2012 | 7.508M |
July 31, 2012 | 7.508M |
January 31, 2012 | 3.778M |
July 31, 2011 | 5.767M |
January 31, 2011 | 5.820M |
July 31, 2010 | 10.27M |
January 31, 2010 | 13.22M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
36.86M
Minimum
Sep 2020
437.92M
Maximum
Sep 2024
113.12M
Average
91.33M
Median
Shareholders Equity (Quarterly) Benchmarks
Merck & Co Inc | 44.50B |
Terns Pharmaceuticals Inc | 364.47M |
Instil Bio Inc | 176.33M |
Viking Therapeutics Inc | 911.45M |
Moderna Inc | 11.93B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 502.85M |
Total Liabilities (Quarterly) | 64.93M |